There are many good reasons to give large quantities of ascorbate (vitamin C) to a cancer patient. Ascorbate strengthens the collagen “glue” that holds healthy cells together and retards the spread of an existing tumor. The vitamin also greatly strengthens the immune system, and provides a surprising level of pain relief. But there is more. Vitamin C has been shown to be preferentially toxic to tumor cells, similar to cytotoxic drug cancer chemotherapy. Laboratory and clinical studies indicate that, in high enough doses, one can maintain blood plasma concentrations of ascorbate high enough to selectively kill tumor cells. If you have not heard about this, it is probably because most of the best-publicized vitamin C and cancer studies simply have not utilized high enough doses. Hugh D. Riordan, M.D., and colleagues have treatment data which “demonstrate the ability to sustain plasma levels of ascorbic acid in humans above levels which are toxic to tumor cells in vitro and suggests the feasibility of using AA as a cytotoxic chemotherapeutic agent.” Dr. Santos uses Intravenous Vitamin C quite frequently in the treatment of cancer. He has found that his patients experience less side effects from chemotherapy and radiation as well as reduces the pain associated with cancer.
Intravenous Vitamin C therapy is usually combined with Ozone therapy and Intravenous Sodium Bicarbonate for Cancer. He also has a number of patients who's tumor markers has reduced steadily while on the treatment. Intravenous vitamin C is typically used with patient while on chemotherapy and radiation. A typical cancer patient will receive 50 grams of intravenous vitamin C 2-3 times a week. The cost is $105.